The instructions for Abbott's Amplatzer Amulet Left Atrial Appendage Occluder now include more details about minimizing the risk of pulmonary artery injury. This a Class II recall, but no devices need to be returned. The instructions for Abbott's Amplatzer Amulet Left Atrial Appendage Occluder now include more details about minimizing the risk of pulmonary artery injury. This a Class II recall, but no devices need to be returned. | | |
|
Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. | | |
|
Cardiac surgeon compensation is up 11%, according to new survey data from MedAxiom and the American College of Cardiology. Vascular surgeons experienced an increase in pay as well, but it was much smaller. Cardiac surgeon compensation is up 11%, according to new survey data from MedAxiom and the American College of Cardiology. Vascular surgeons experienced an increase in pay as well, but it was much smaller. | | |
|
AI has made a significant impact on the way clinicians use CCTA. For example, what were once time-consuming manual measurements are now performed automatically in the blink of an eye. AI has made a significant impact on the way clinicians use CCTA. For example, what were once time-consuming manual measurements are now performed automatically in the blink of an eye. | | |
|
According to Elucid, the development of its FFR-IQ software was guided by clinician feedback. According to Elucid, the development of its FFR-IQ software was guided by clinician feedback. | | |
|
ASNC focuses on selecting the appropriate examination for each patient rather than treating one modality as universally preferable. At the same time, cardiac PET has been linked to key benefits that could improve patient care if only more clinicians could use it. ASNC's next president, Andrew Einstein, MD, PhD, discussed this and more in a new interview. ASNC focuses on selecting the appropriate examination for each patient rather than treating one modality as universally preferable. At the same time, cardiac PET has been linked to key benefits that could improve patient care if only more clinicians could use it. ASNC's next president, Andrew Einstein, MD, PhD, discussed this and more in a new interview. | | |
|
A new FDA-approved pulmonary valve should reduce the number of open-heart surgeries children with congenital heart disease require as they grow older. Emile Bacha, MD, explained the importance of this device in a new video interview. A new FDA-approved pulmonary valve should reduce the number of open-heart surgeries children with congenital heart disease require as they grow older. Emile Bacha, MD, explained the importance of this device in a new video interview. | | |
|
Researchers tracked years of real-world data, noting that the mortality rates for TAVR and SAVR were comparable once patients were discharged. Researchers tracked years of real-world data, noting that the mortality rates for TAVR and SAVR were comparable once patients were discharged. | | |
|
CCTA offers clinicians an opportunity to make patient care more efficient. However, interventionalists need to make sure they understand how to properly interpret coronary CT data. CCTA offers clinicians an opportunity to make patient care more efficient. However, interventionalists need to make sure they understand how to properly interpret coronary CT data. | | |
|
The Shockwave C2 Aero Fly Coronary IVL Catheter from Johnson & Johnson MedTech is now available. In addition, the company announced, the next-generation device will be featured in its booth at TCT 2026. The Shockwave C2 Aero Fly Coronary IVL Catheter from Johnson & Johnson MedTech is now available. In addition, the company announced, the next-generation device will be featured in its booth at TCT 2026. | | |
|
Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair. Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair. | | |
|
